Brief: Amneal Receives U.S. FDA Approval Of New Drug Application For Pyridostigmine Bromide Extended-Release Tablets
21/10/2024 16:27
Oct 21 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL RECEIVES U.S. FDA APPROVAL OF NEW DRUG APPLICATION
FOR
PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS
Source text for Eikon: ID:nBw6hFfMra
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study